You have 9 free searches left this month | for more free features.

City

Suzhou (1)

Taiyuan (1)

Condition

Relapsed or Refractory Acute Myeloid Leukemia (1)

Relapsed/Refractory AML (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

n/a (1)

phase 1 (1)

Sponsor

Shanxi Bethune Hospital (1)

The First Affiliated Hospital of Soochow University (1)

Collaborator

Antengene Corporation (1)

Intervention

aclacinomycin (2)

cytarabine (2)

granulocyte colony-stimulating factor (2)

homoharringtonine (2)

selinexor (2)

azacitidine (1)

daunorubicin (1)

decitabine (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

aclacinomycin

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Relapsed/Refractory AML Trial in Suzhou (Selinexor, Homoharringtonine, Cytarabine)

Not yet recruiting

Relapsed/Refractory AML

Selinexor
+6 more

Suzhou, Jiangsu, China

The First Affiliated Hospital of Soochow University

Mar 28, 2023

Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

Recruiting

Relapsed or Refractory Acute Myeloid Leukemia

Selinexor
+5 more

Taiyuan, Shanxi, China

Tao Wang

Feb 9, 2023